Medtronic
MDT
2,081 hedge funds and large institutions have $95.7B invested in Medtronic in 2024 Q1 according to their latest regulatory filings, with 176 funds opening new positions, 938 increasing their positions, 729 reducing their positions, and 145 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 938 | Existing positions reduced: 729
21% more first-time investments, than exits
New positions opened: 176 | Existing positions closed: 145
6% more capital invested
Capital invested by funds: $89.9B → $95.7B (+$5.81B)
0.68% more ownership
Funds ownership: 82.04% → 82.72% (+0.68%)
0% more funds holding
Funds holding: 2,078 → 2,081 (+3)
3% less funds holding in top 10
Funds holding in top 10: 32 → 31 (-1)
17% less call options, than puts
Call options by funds: $643M | Put options by funds: $778M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$533M |
| 2 |
Morgan Stanley
New York
|
+$318M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$271M |
| 4 |
National Pension Service
Jeonju-Si, Jeollabuk-Do,
South Korea
|
+$194M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$191M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$440M |
| 2 |
BlackRock
New York
|
-$392M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$290M |
| 4 |
Millennium Management
New York
|
-$279M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$189M |
MDT Hedge Fund Activity: Q1 2024 in Review
2,081 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q1 2024, worth a combined $95.7B — up 6.5% from $89.9B a quarter earlier.
Buyers outnumbered sellers: 176 funds opened new MDT positions and 145 closed out — a net gain of 31 holders — while 938 added to existing stakes and 729 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $533M. The largest seller was Wells Fargo, cutting an estimated $440M.
- 2,081 institutional investors held Medtronic (MDT) as of Q1 2024, up from 2,078 in Q4 2023.
- Funds reported $95.7B of Medtronic stock for Q1 2024, up 6.5% quarter-over-quarter.
- 176 funds opened new Medtronic positions in Q1 2024 and 145 closed out, a net change of +31 holders.
- The largest Medtronic buyer in Q1 2024 was JP Morgan Chase, an estimated $533M added.
- The largest Medtronic seller in Q1 2024 was Wells Fargo, an estimated $440M sold.
Based on aggregated 13F filings for Q1 2024.